Table 1.
Characteristics of the patients
| Characteristics | MF/SS patients with negative PCR for COVID-19 (N = 704) | MF/SS patients with positive PCR for COVID-19 (N = 768) | p value |
|---|---|---|---|
| Age | <0.001 | ||
| Mean (SD) | 62.804 (15.412) | 59.549 (14.587) | |
| Median (Q1, Q3) | 64.756 (53.457, 73.540) | 60.368 (49.934, 70.048) | |
| Gender, n (%) | 0.905 | ||
| Female | 239 (33.9) | 263 (34.2) | |
| Male | 465 (66.1) | 505 (65.8) | |
| Socioeconomic performance index | 0.203 | ||
| Mean (SD) | 6.940 (2.269) | 7.091 (2.269) | |
| Median (Q1, Q3) | 7,000 (6,000, 9,000) | 7,000 (6,000, 9,000) | |
| Disease, n (%) | 0.518 | ||
| Mycosis fungoides | 693 (98.4) | 759 (98.8) | |
| Sezary syndrome | 11 (1.6) | 9 (1.2) | |
| Other neoplasm, n (%) | |||
| Breast | 12 (1.7) | 18 (2.3) | 0.386 |
| Digestive organs | 13 (1.8) | 15 (2.0) | 0.881 |
| Male genital organs | 16 (2.3) | 26 (3.4) | 0.2 |
| Other skin | 103 (14.6) | 103 (13.4) | 0.501 |
| Other comorbidity, n (%) | |||
| Dementia | 40 (5.7) | 27 (3.5) | 0.046 |
| BMI | 0.001 | ||
| Normal | 326 (46.3) | 285 (37.1) | |
| Obesity | 148 (21.0) | 181 (23.6) | |
| Overweight | 196 (27.8) | 271 (35.3) | |
| Underweight | 34 (4.8) | 31 (4.0) | |
| Hypertension | 343 (48.7) | 322 (41.9) | 0.009 |
| Cardiovascular | 127 (18.0) | 122 (15.9) | 0.271 |
| COPD | 45 (6.4) | 36 (4.7) | 0.152 |
| Kidney failure | 224 (31.8) | 208 (27.1) | 0.046 |
| Diabetes mellitus | 145 (20.6) | 170 (22.1) | 0.472 |
| Osteoporosis | 152 (21.6) | 119 (15.5) | 0.003 |